SCHEMBL19494503

SCHEMBL19494503

CN(CC(F)F)S(=O)(=O)c1cc(C(N)O)c(NC(=O)c2ccccc2F)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.39
▸ LMNA P02545 4/20 0.39
▸ MAPT P10636 4/20 0.39
▸ POLB P06746 1/20 0.39
▸ TP53 P04637 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 5/20 0.37
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ HTT P42858 3/20 0.36
▸ PKM P14618 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PTPRC P08575 2/20 0.36
▸ CTSL P07711 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16246257 0.86 CFTR (0.52) CFTRLMNAMAPTPOLBTP53
SCHEMBL28156782 0.80 LMNA (0.42) LMNAMAPTPOLBTP53KDM4E
SCHEMBL19494890 0.75 KDM4E (0.48) LMNAMAPTPOLBKDM4EALDH1A1
SCHEMBL16387398 0.74 CFTR (0.52) CFTRLMNAMAPTPOLBTP53
SCHEMBL16246540 0.74 CFTR (0.52) CFTRLMNAMAPTPOLBTP53
SCHEMBL16246408 0.74 CFTR (0.68) CFTRLMNAMAPTPOLBTP53
SCHEMBL16246482 0.73 CFTR (0.50) CFTRLMNAMAPTPOLBKDM4E
SCHEMBL16263734 0.73 CFTR (0.51) CFTRLMNAMAPTPOLBTP53
SCHEMBL16246311 0.73 CFTR (0.51) CFTRLMNAMAPTPOLBTP53
SCHEMBL16246499 0.72 CFTR (0.50) CFTRLMNAMAPTPOLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback